|
|||||
|
|
Prognostic role of pathologic response and cytoreductive status at interval debulking surgery after neoadjuvant chemotherapy for advanced epithelial ovarian cancer |
|
| Authors: | Margaret I Liang MD Emily N Prendergast MD Jeanine N Staples MD Christine H Holschneider MD Joshua G Cohen MD Ilana Cass MD |
| Institution: | 1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California;2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles Medical Center, Los Angeles, California Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Olive View Hospital–University of California Los Angeles Medical Center, Sylmar, California;3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Olive View Hospital–University of California Los Angeles Medical Center, Sylmar, California;4. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles Medical Center, Los Angeles, California |
| Abstract: | |
| Keywords: | complete pathologic response cytoreduction surgical procedures neoadjuvant therapy ovarian epithelial cancer |